Tamoxifen: A new risk factor for cerebral sinus thrombosis

Neurology

Volumn 62, Issue 2, 2004, Pages 334-335

  Masjuan, J ^a   Pardo, J ^b   Callejo, J M ^a   Andres M T ^c   Alvarez Cermeno J C ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^c Sanatorio Nuestra Senora del Rosario   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BREAST CANCER; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0842346588     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000103294.81923.12     Document Type: Article

References (7)

1. Raizer JJ, De Angelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000;54:1222-1226.
2. O'Regan RM, Gradishar WJ. Selective estrogen-receptor modulators in 2001. Oncology 2001;15:1177-1185.
3. Finelli PF, Schauer PK. Cerebral sinus thrombosis with tamoxifen. Neurology 2001;56:1113-1114.
4. Akdal G, Dönmez B, Cakmakci H, Yener GG. A case with cerebral thrombosis receiving tamoxifen treatment. Eur J Neurol 2001;8:723-724.
5. Stam J, de Bruijn SFTM, DeVeber G. Anticoagulation for cerebral sinus thrombosis (Cochrane review). In: Cochrane Library, issue 4. Oxford: Update Software, 2002.
6. Cushman M, Constantino JP, Bovill EG, et al. Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial. Br J Haematol 2003;120:109-116.
7. Baum M, Budzar AU, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC Randomised Trial. Lancet 2002;359:2131-2139.